Association of zinc deficiency and insulin resistance in hemodialysis patients using artificial pancreas

Association of zinc deficiency and insulin resistance in hemodialysis patients using artificial pancreas - AZIHAP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045209

Enrollment

Registered

2021-11-01

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc deficiency

Interventions

Hemodialyzed patients with zinc deficiency and latent zinc deficiency are supplemented with zinc 50 mg / dL for 6 weeks, and insulin resistance is evaluated by the glucose clamp method before and afte

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients on hemodialysis who have zinc deficiency and latent zinc deficiency.

Exclusion criteria

Exclusion criteria: Patients with zinc deficiency and latent zinc deficiency

Design outcomes

Primary

Measure	Time frame
Hemodialyzed patients with zinc deficiency and latent zinc deficiency are supplemented with zinc for 6 weeks and insulin resistance is assessed by glucose clamp before and after that.	—

Countries

Japan

Contacts

Public ContactRyunosuke Mitsuno

International University of Health and Welfare, Narita Hospital Department of Nephrology

r-mitsuno-p-k@iuhw.ac.jp0476355600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026